International Journal of Cardiology
Volume 127, Issue 1 , Pages 40-45, 23 June 2008

Value of right ventricular dysfunction for prognosis in pulmonary embolism

  • Ling Zhu

      Affiliations

    • Department of Respiratory Medicine, Shandong Provincial Hospital, Shandong University, Jinan, China
    • Now studying in Beijing Chao-yang Hospital.
  • ,
  • Yuanhua Yang

      Affiliations

    • Beijing Institute of Respiratory Medicine, Beijing Chao-yang Hospital, Capital University of Medical Sciences, Beijing 100020, China
  • ,
  • Yafeng Wu

      Affiliations

    • Department of Ultrasonography, Beijing Chao-yang Hospital, Capital University of Medical Sciences, Beijing, China
  • ,
  • Zhenguo Zhai

      Affiliations

    • Beijing Institute of Respiratory Medicine, Beijing Chao-yang Hospital, Capital University of Medical Sciences, Beijing 100020, China
  • ,
  • Chen Wang

      Affiliations

    • Beijing Institute of Respiratory Medicine, Beijing Chao-yang Hospital, Capital University of Medical Sciences, Beijing 100020, China
    • Corresponding Author InformationCorresponding author. Tel.: +86 10 85231893; fax: +86 10 65060167.

Received 3 July 2006; received in revised form 24 June 2007; accepted 30 June 2007. published online 23 August 2007.

Abstract 

Background

Acute pulmonary embolism (APE) patients with right ventricular dysfunction (RVD) have a worse prognosis. We assessed RVD, deciding the indexes correlating best with prognosis.

Methods

The prospective multi-center study included 520 consecutive APE patients from 41 collaborating hospitals in China, between June 2002 and November 2004. RVD was diagnosed in the presence of at least 2 of the following: right ventricular (RV) dilatation, loss of inspiratory collapse of inferior vena cava (IVC), right ventricular hypokinesis, tricuspid regurgitant jet velocity >2.8 m/s.

Results

Mean age was 57.4±14.1 years and 323 patients (62.1%) were male. The 14-day mortality in normotensive patients with RVD was higher (2.0% vs 0.4%, p<0.01) than without RVD. RVD was associated with adverse 14-day outcomes (OR 5.23, 95% CI, 2.44–11.23) and the combination of RV dilation and IVC broadening was more valuable than the combination of RV dilation and RV hypokinesis (p<0.01). A multiple logistic regression model implied that RVD, right/left ventricular end-diastolic diameter ratio (RVED/LVED) and systolic pulmonary artery pressure (SPAP) be independent predictors of adverse 14-day clinical outcomes (p<0.01). ROC curve showed that the best cut-off values of RVED/LVED and SPAP were 0.67 and 60 mm Hg, respectively. Hemodynamic instability, 14-day clinical outcome, and SPAP were independent harbingers for 3-month outcomes (p<0.01).

Conclusions

RVD was a discriminator for a poor prognosis in normotensive patients. Early detection of RVD (especially combination of RV dilation and IVC broadening, RVED/LVED>0.67 and/or SPAP>60 mm Hg) was beneficial for identifying high-risk patients. Hemodynamic instability, 14-day clinical outcomes, and SPAP independently predicted 3-month clinical outcomes.

Abbreviations: APE, acute pulmonary embolism, PE, pulmonary embolism, RVD, right ventricular dysfunction, CTPA, computed tomographic pulmonary angiography, TTE, transthoracic echocardiography, RVED/LVED, right and left ventricular end-diastolic diameter ratio in the parasternal long-axis view, SPAP, systolic pulmonary artery pressure, IVC, inferior vena cava, PAA, pulmonary artery angiography.

Keywords: Pulmonary embolism, Right ventricular dysfunction, Transthoracic echocardiography, Prognosis

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 This study was supported by a grant (2004BA703B07) from National Project of the Diagnosis and Treatment Strategies for Pulmonary Thromboembolism in China (NATSPUTE).

PII: S0167-5273(07)01258-2

doi:10.1016/j.ijcard.2007.06.093

International Journal of Cardiology
Volume 127, Issue 1 , Pages 40-45, 23 June 2008